Management of Women Who Experience Domestic Abuse: Study Comparing Psychological Outcomes at the Maison Des Femmes in Saint-Denis and a Convential Shelter (AVEC-L)

Management of Women Who Experience Domestic Abuse: a Feasibility Study Comparing Psychological Outcomes at the Maison Des Femmes in Saint-Denis and a Convential Shelter

ach year, it is estimated that an average of approximately 219,000 women in France suffer physical and/or sexual violence at the hands of their partner or ex-partner. These figures do not take into account other types of violence such as psychological or economic violence. Domestic violence has a major impact on the physical, sexual and psychological health of women victims. For example, the prevalence of post-traumatic stress disorder in these women varies between 33 and 84%, with an average prevalence of 61%, compared with only 2.2% in the French population as a whole. Multidisciplinary medical, social and legal support for these women is essential. In France, there are major territorial disparities in terms of the distribution of facilities for victims of domestoc violence, and not all women victims have the same access to care depending on their place of residence.

The Maison des Femmes in St Denis has been open since 2016. It offers a unique range of sanitary, social and judicial services through cooperation with police and justice departments, for women who have been subjected to any type of violence.

This facility is unique in France, and the number of consultations continues to increase, and was more than 8,500 in 2018. The Maison des Femmes model is intended to be exported to other departments, but first the model needs to be validated, beyond its obvious attractiveness (illustrated by the number of consultations and the fact that it attracts women from throughout the Ile de France region) by comparing it to other facilities in terms of its effect on the management of the women.

This is a cross-sectional prevalence study that estimates the frequency of post-traumatic stress disorder among women who are victims of domestic violence who used the services offered at the Maison des Femmes or other dedicated structures, at the initial consultation and 6 months later.

Study Overview

• Status: Completed
• Conditions: Domestic Violence
• Intervention / Treatment: Other: surveys; Other: follow-up

• Study Type: Observational
• Enrollment (Actual): 67

Contacts and Locations

Study Locations

• France
  • Dijon, France, 21000
    • Chu Dijon Bourgogne

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: Female

• Sampling Method: Non-Probability Sample

Study Population

women consulting for domestic violence

Description

Inclusion Criteria:

• Female aged 18 and over,
• Consulted for domestic violence at the Maison des Femmes, St Denis health centre or Aubervilliers health centre.
• Able to understand the objectives of the study and to respond to the survey
• Having been informed and not having objected to participating in this study.

Exclusion Criteria:

• Unable to understand the objectives of the study and to respond to the surveys.
• Consulting for another reason.
• Protected adult under a measure of safeguard.

Study Plan

How is the study designed?

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
women; women consulting for domestic violence	Other: surveys; delivery of the survey at a domestic violence consultation; Other: follow-up; follow-up of women 6 months after their consultation

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Time Frame
Prevalence of Post-Traumatic Stress Disorder by PCL-5 Scale	at the end of study, an average of 6 months

Collaborators and Investigators

• Sponsor: Centre Hospitalier Universitaire Dijon

Study record dates

Study Major Dates

• Study Start (Actual): June 23, 2020
• Primary Completion (Actual): June 24, 2021
• Study Completion (Actual): December 21, 2021

Study Registration Dates

• First Submitted: March 9, 2020
• First Submitted That Met QC Criteria: March 10, 2020
• First Posted (Actual): March 11, 2020

Study Record Updates

• Last Update Posted (Actual): February 10, 2022
• Last Update Submitted That Met QC Criteria: February 9, 2022
• Last Verified: February 1, 2022

More Information

Terms related to this study

• Other Study ID Numbers: BARDOU THELLIE 2019

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No